US Patent 7816084 TLE3 as a marker for chemotherapy
Patent 7816084 was granted and assigned to Applied Genomics, Inc. on October, 2010 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7816084 TLE3 as a marker for chemotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
